AAAAAA

   
Results: 1-25 |
Results: 25
CHANGES IN ONCOGENE EXPRESSION IMPLICATED IN EVOLUTION OF CHRONIC GRANULOCYTIC-LEUKEMIA FROM ITS CHRONIC PHASE TO ACCELERATION
Authors: BECK Z BACSI A KOVACS E KISS J KISS A BALOGH E TELEK B TOTH FD ANDIRKO I OLAH E UDVARDY M RAK K
Citation: Z. Beck et al., CHANGES IN ONCOGENE EXPRESSION IMPLICATED IN EVOLUTION OF CHRONIC GRANULOCYTIC-LEUKEMIA FROM ITS CHRONIC PHASE TO ACCELERATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 293-306
IVERSEN,OLAV,HILMAR 1923-1997 - IN-MEMORIAM
Authors: OLAH E POTTEN CS
Citation: E. Olah et Cs. Potten, IVERSEN,OLAV,HILMAR 1923-1997 - IN-MEMORIAM, Cell proliferation, 31(2), 1998, pp. 111-112
FLUORESCENCE IN-SITU HYBRIDIZATION REVEALS TRISOMY 2Q BY INSERTION INTO 9P IN HEPATOBLASTOMA
Authors: BALOGH E SWANTON S KISS C JAKAB ZS SECKERWALKER LM OLAH E
Citation: E. Balogh et al., FLUORESCENCE IN-SITU HYBRIDIZATION REVEALS TRISOMY 2Q BY INSERTION INTO 9P IN HEPATOBLASTOMA, Cancer genetics and cytogenetics, 102(2), 1998, pp. 148-150
CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS
Authors: PHELAN CM BORG A CUNY M CRICHTON DN BALDERSSON T ANDERSEN TI CALIGO MA LIDEREAU R LINDBLOM A SEITZ S KELSELL D HAMANN K RIO P THORLACIUS S PAPP J OLAH E PONDER B BIGNON YJ SCHERNECK S BARKARDOTTIR R BORRESENDALE AL EYFJORD J THEILLET C THOMPSON AM DEVILEE P LARSSON C
Citation: Cm. Phelan et al., CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS, Cancer research, 58(5), 1998, pp. 1004-1012
HAPLOTYPE AND PHENOTYPE ANALYSIS OF 9 RECURRENT BRCA2 MUTATIONS IN 111 FAMILIES - RESULTS OF AN INTERNATIONAL STUDY
Authors: NEUHAUSEN SL GODWIN AK GERSHONIBARUCH R SCHUBERT E GARBER J STOPPALYONNET D OLAH E CSOKAY B SEROVA O LALLOO F OSORIO A STRATTON M OFFIT K BOYD J CALIGO MA SCOTT RJ SCHOFIELD A TEUGELS E SCHWAB M CANNONALBRIGHT L BISHOP T EASTON D BENITEZ J KING MC PONDER BAJ WEBER B DEVILEE P BORG A NAROD SA GOLDGAR D
Citation: Sl. Neuhausen et al., HAPLOTYPE AND PHENOTYPE ANALYSIS OF 9 RECURRENT BRCA2 MUTATIONS IN 111 FAMILIES - RESULTS OF AN INTERNATIONAL STUDY, American journal of human genetics, 62(6), 1998, pp. 1381-1388
A BREAST OVARIAN CANCER-PATIENT WITH GERMLINE MUTATIONS IN BOTH BRCA1AND BRCA2/
Authors: RAMUS SJ FRIEDMAN LS GAYTHER SA PONDER BAJ BOBROW LG VANDERLOOJI M PAPP J OLAH E
Citation: Sj. Ramus et al., A BREAST OVARIAN CANCER-PATIENT WITH GERMLINE MUTATIONS IN BOTH BRCA1AND BRCA2/, Nature genetics, 15(1), 1997, pp. 14-15
LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP
Authors: DEVILEE P HERMANS J EYFJORD J BORRESEN AL LIDEREAU R SOBOL H BORG A CLETONJANSEN AM OLAH E COHEN B SCHERNECK S HAMANN U PETERLIN B CALIGO M BIGNON YL MAUGARD C ANDERSEN TI ODEGAND AEM BIECHE I BIRNBAUM D CORNELISSE CJ SZTAN M STEEL MR SEITZ S LOGAR N GOLOUH R GHIMENTI C BRUELLE S JOALLAND MP
Citation: P. Devilee et al., LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP, Genes, chromosomes & cancer, 18(3), 1997, pp. 193-199
FISH CONFIRMS THE IMPORTANCE OF TRISOMY 2Q IN HEPATOBLAS-TOMA
Authors: BALOGH E SWANTON S KISS C JAKAB Z SECKERWALKER LM OLAH E
Citation: E. Balogh et al., FISH CONFIRMS THE IMPORTANCE OF TRISOMY 2Q IN HEPATOBLAS-TOMA, Cytogenetics and cell genetics, 77(1-2), 1997, pp. 352-352
IS P53 EXPRESSION, DETECTED BY IMMUNOHISTOCHEMISTRY, AN IMPORTANT PARAMETER OF RESPONSE TO TREATMENT IN TESTIS CANCER
Authors: EID H VANDERLOOIJ M INSTITORIS E GECZI L BODROGI I OLAH E BAK M
Citation: H. Eid et al., IS P53 EXPRESSION, DETECTED BY IMMUNOHISTOCHEMISTRY, AN IMPORTANT PARAMETER OF RESPONSE TO TREATMENT IN TESTIS CANCER, Anticancer research, 17(4A), 1997, pp. 2663-2669
MOLECULAR MECHANISMS IN THE ANTIPROLIFERATIVE ACTION OF QUERCETIN
Authors: CSOKAY B PRAJDA N WEBER G OLAH E
Citation: B. Csokay et al., MOLECULAR MECHANISMS IN THE ANTIPROLIFERATIVE ACTION OF QUERCETIN, Life sciences, 60(24), 1997, pp. 2157-2163
ANALYSIS OF BRCA1 AND BRCA2 MUTATIONS IN HUNGARIAN FAMILIES WITH BREAST OR BREAST-OVARIAN CANCER
Authors: RAMUS SJ KOTEJARAI Z FRIEDMAN LS VANDERLOOIJ M GAYTHER SA CSOKAY B PONDER BA OLAH E
Citation: Sj. Ramus et al., ANALYSIS OF BRCA1 AND BRCA2 MUTATIONS IN HUNGARIAN FAMILIES WITH BREAST OR BREAST-OVARIAN CANCER, American journal of human genetics, 60(5), 1997, pp. 1242-1246
ALLELE LOSS OF TUMOR-SUPPRESSOR GENES ON CHROMOSOME-17 IN HUMAN TESTICULAR GERM-CELL TUMORS
Authors: VANDERLOOIJ M EID H BAK M BODROGI I OLAH E
Citation: M. Vanderlooij et al., ALLELE LOSS OF TUMOR-SUPPRESSOR GENES ON CHROMOSOME-17 IN HUMAN TESTICULAR GERM-CELL TUMORS, International journal of oncology, 9(5), 1996, pp. 1087-1090
SPECIAL FEATURES OF CHILDHOOD AND JUVENILE THYROID CARCINOMAS
Authors: BALAZS G LUKACS G JUHASZ F GYORY F OLAH E BALOGH E
Citation: G. Balazs et al., SPECIAL FEATURES OF CHILDHOOD AND JUVENILE THYROID CARCINOMAS, SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 26(7), 1996, pp. 536-540
MULTIDRUG-RESISTANCE OF TESTIS CANCERS - THE STUDY OF CLINICAL RELEVANCE OF P-GLYCOPROTEIN EXPRESSION
Authors: EID H BODROGI I CSOKAY B OLAH E BAK M
Citation: H. Eid et al., MULTIDRUG-RESISTANCE OF TESTIS CANCERS - THE STUDY OF CLINICAL RELEVANCE OF P-GLYCOPROTEIN EXPRESSION, Anticancer research, 16(6B), 1996, pp. 3447-3452
MOLECULAR MECHANISMS IN THE ANTIPROLIFERATIVE ACTION OF TAXOL AND TIAZOFURIN
Authors: OLAH E CSOKAY B PRAJDA N KOTEJARAI Z YEH YA WEBER G
Citation: E. Olah et al., MOLECULAR MECHANISMS IN THE ANTIPROLIFERATIVE ACTION OF TAXOL AND TIAZOFURIN, Anticancer research, 16(5A), 1996, pp. 2469-2477
INITIAL GENETIC DIAGNOSIS IN ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
Authors: OLAH E BALOGH E JAKAB Z KISS C
Citation: E. Olah et al., INITIAL GENETIC DIAGNOSIS IN ACUTE LYMPHOCYTIC-LEUKEMIA (ALL), Pediatric research, 39(4), 1996, pp. 947-947
ALLELE LOSS FROM LARGE REGIONS OF CHROMOSOME-17 IS COMMON ONLY IN CERTAIN HISTOLOGICAL SUBTYPES OF OVARIAN CARCINOMAS
Authors: PAPP J CSOKAY B BOSZE P ZALAY Z TOTH J PONDER B OLAH E
Citation: J. Papp et al., ALLELE LOSS FROM LARGE REGIONS OF CHROMOSOME-17 IS COMMON ONLY IN CERTAIN HISTOLOGICAL SUBTYPES OF OVARIAN CARCINOMAS, British Journal of Cancer, 74(10), 1996, pp. 1592-1597
CONTRIBUTION OF P53 GENE ALTERATIONS TO DEVELOPMENT OF METASTATIC FORMS OF FOLLICULAR THYROID-CARCINOMA
Authors: SAPI Z LUKACS G SZTAN M PAPP J OLAH E
Citation: Z. Sapi et al., CONTRIBUTION OF P53 GENE ALTERATIONS TO DEVELOPMENT OF METASTATIC FORMS OF FOLLICULAR THYROID-CARCINOMA, Diagnostic molecular pathology, 4(4), 1995, pp. 256-260
HIGH ALLELE LOSS RATES AT 17Q12-Q21 IN BREAST AND OVARIAN-TUMORS FROMBRCA1-LINKED FAMILIES
Authors: CORNELIS RS NEUHAUSEN SL JOHANSSON O ARASON A KELSELL D PONDER BAJ TONIN P HAMANN U LINDBLOM A LALLE P LONGY M OLAH E SCHERNECK S BIGNON YJ SOBOL H CHANGCLAUDE J LARSSON C SPURR N BORG A BARKARDOTTIR RB NAROD S DEVILEE P
Citation: Rs. Cornelis et al., HIGH ALLELE LOSS RATES AT 17Q12-Q21 IN BREAST AND OVARIAN-TUMORS FROMBRCA1-LINKED FAMILIES, Genes, chromosomes & cancer, 13(3), 1995, pp. 203-210
CHILDHOOD AND JUVENILE THYROID CARCINOMAS
Authors: GYORY F BALAZS G LUKACS G JUHASZ F OLAH E BALOGH E
Citation: F. Gyory et al., CHILDHOOD AND JUVENILE THYROID CARCINOMAS, European journal of cancer, 31A, 1995, pp. 535-535
LINKAGE OF REDUCTION IN 1-PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY AND INOSITOL 1,4,5-TRISPHOSPHATE CONCENTRATION IN HUMAN OVARIAN-CARCINOMA CELLS TREATED WITH QUERCETIN
Authors: PRAJDA N SINGHAL RL YEH YA OLAH E LOOK KY WEBER G
Citation: N. Prajda et al., LINKAGE OF REDUCTION IN 1-PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY AND INOSITOL 1,4,5-TRISPHOSPHATE CONCENTRATION IN HUMAN OVARIAN-CARCINOMA CELLS TREATED WITH QUERCETIN, Life sciences, 56(19), 1995, pp. 1587-1593
QUERCETIN DOWN-REGULATES SIGNAL BREAST-CARCINOMA TRANSDUCTION IN HUMAN-CELLS
Authors: SINGHAL RL YEH YA PRAJDA N OLAH E SLEDGE GW WEBER G
Citation: Rl. Singhal et al., QUERCETIN DOWN-REGULATES SIGNAL BREAST-CARCINOMA TRANSDUCTION IN HUMAN-CELLS, Biochemical and biophysical research communications, 208(1), 1995, pp. 425-431
TRANSLOCATION 8-21 ASSOCIATED WITH ACUTE NONLYMPHOCYTIC LEUKEMIA IN ADOWN-SYNDROME CHILD
Authors: BALOGH E OLAH E HUNYADI K
Citation: E. Balogh et al., TRANSLOCATION 8-21 ASSOCIATED WITH ACUTE NONLYMPHOCYTIC LEUKEMIA IN ADOWN-SYNDROME CHILD, Cancer genetics and cytogenetics, 76(1), 1994, pp. 72-73
COEXPRESSION OF C-ABL AND C-MYB ONCOGENES IN PHILADELPHIA CHROMOSOME-NEGATIVE, BCR-NEGATIVE CHRONIC MYELOID-LEUKEMIA
Authors: TOTH FD KISS J KISS A TELEK B OLAH E IVANYI J RAK K
Citation: Fd. Toth et al., COEXPRESSION OF C-ABL AND C-MYB ONCOGENES IN PHILADELPHIA CHROMOSOME-NEGATIVE, BCR-NEGATIVE CHRONIC MYELOID-LEUKEMIA, Leukemia research, 18(5), 1994, pp. 373-380
SYNERGISTIC ACTION OF TAXOL WITH TIAZOFURIN AND METHOTREXATE IN HUMANBREAST-CANCER CELLS - SCHEDULE-DEPENDENCE
Authors: YEH YA OLAH E WENDEL JJ SLEDGE GW WEBER G
Citation: Ya. Yeh et al., SYNERGISTIC ACTION OF TAXOL WITH TIAZOFURIN AND METHOTREXATE IN HUMANBREAST-CANCER CELLS - SCHEDULE-DEPENDENCE, Life sciences, 54(24), 1994, pp. 431-435
Risultati: 1-25 |